About Novotech – The Asia Pacific Biotech CRO With Global Execution Capabilities

Biopharmaceutical Sponsors are facing increased challenges around participant recruitment and retention, lengthy timeframes, and trial costs. At the same time, sponsors are also looking to achieve greater diversification of their clinical trial participants and bring their innovative therapies to global patient populations.

On a global scale, Novotech’s focus on local relationships and expertise allows our clients to access a diverse, global patient population while also including regions of the world with faster patient recruitment. To reach these study goals, Asia-Pacific has become a key location, driven by its large patient population, the scale of medical facilities, government support for clinical trials, the strategic importance of Asian economies as end consumer markets, lower trial costs, and high-quality standards.

Take advantage of the world’s fastest-growing clinical trials region to accelerate your global clinical development by leveraging Novotech’s global footprint, deep relationships, and global operational infrastructure.